serum
antibodi
sever
acut
respiratori
syndrom
sar
coronaviru
sar
patient
check
month
everi
month
diseas
onset
except
one
miss
blood
sampl
month
test
posit
immunoglobulin
g
igg
antibodi
month
fifteen
test
posit
igm
antibodi
month
serum
igm
antibodi
patient
becam
undetect
within
month
onset
sar
igg
antibodi
patient
whose
serum
check
year
diseas
onset
remain
posit
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
caus
global
epidem
high
mortal
rate
diseas
easi
transmiss
health
care
worker
character
clinic
import
clinic
manifest
laboratori
find
radiolog
present
outcom
sar
patient
well
describ
previou
report
also
found
specif
antibodi
sarsassoci
coronaviru
sarscov
appear
earli
day
diseas
onset
high
level
antibodi
could
last
month
onset
sar
howev
studi
concern
longterm
evolut
specif
antibodi
includ
immunoglobulin
g
igg
igm
sarscov
remain
limit
studi
conduct
nation
taiwan
univers
hospit
ntuh
illumin
issu
sar
epidem
taiwan
sar
patient
pneumonia
identifi
treat
ntuh
sixtyon
patient
surviv
sar
diseas
among
patient
patient
regularli
subject
followup
exam
outpati
clinic
ntuh
year
discharg
patient
follow
month
discharg
patient
examin
year
sar
diagnos
base
posit
revers
transcriptionpcr
result
sarscov
initi
throat
swab
andor
seroconvers
iggspecif
antibodi
sarscov
patient
maletofemal
ratio
group
age
rang
year
median
age
year
children
includ
studi
patient
pneumon
lesion
chest
accord
radiograph
five
develop
respiratori
failur
cours
diseas
none
previou
underli
diseas
serum
sampl
use
studi
collect
sar
patient
month
month
month
month
month
onset
sar
infect
ten
serum
sampl
healthi
volunt
serum
sampl
adult
patient
bacterem
pneumonia
collect
day
diseas
onset
also
includ
test
comparison
serum
sampl
measur
igmand
iggspecif
antibodi
sarscov
use
commerci
avail
indirect
immunofluoresc
assay
ifa
euroimmun
germani
test
util
slide
coat
sarscovinfect
cell
togeth
noninfect
cell
detect
specif
antibodi
patient
serum
sampl
reaction
serum
dilut
higher
consid
posit
igm
igg
neg
posit
control
provid
test
kit
run
test
test
procedur
use
interpret
result
accord
manufactur
instruct
result
express
reciproc
highest
dilut
serum
gave
posit
fluoresc
reaction
blood
sampl
miss
one
sar
patient
month
three
sar
patient
month
one
sar
patient
month
one
sar
patient
month
one
sar
patient
month
diseas
onset
therefor
total
serum
sampl
sar
patient
blood
sampl
healthi
volunt
adult
patient
bacterem
pneumonia
neg
igm
igg
sarscov
titer
specif
antibodi
initi
creactiv
protein
crp
level
normal
rang
mgdl
sar
patient
well
peak
crp
level
respect
diseas
cours
describ
tabl
geometr
mean
log
igg
titer
sar
patient
illustr
fig
sar
patient
except
patient
whose
serum
sampl
month
diseas
onset
unavail
patient
detect
igm
sarscov
sera
collect
month
diseas
onset
exclus
patient
whose
serum
sampl
collect
month
diseas
onset
igm
antibodi
undetect
patient
month
diseas
onset
patient
month
patient
month
patient
month
peak
serum
igg
titer
patient
except
patient
appear
month
month
diseas
onset
drop
averag
igg
titer
evid
month
month
diseas
onset
patient
except
patient
whose
serum
sampl
collect
month
diseas
onset
detect
igg
antibodi
sera
month
diseas
onset
correl
igg
titer
check
month
diseas
onset
patient
age
initi
crp
level
peak
crp
level
develop
respiratori
failur
determin
statist
analysi
p
respect
prior
studi
point
specif
antibodi
sarscov
appear
earli
day
diseas
onset
high
level
antibodi
last
month
ii
igm
igg
sarscov
appear
almost
time
iii
peak
igg
titer
usual
note
week
diseas
onset
iv
igm
sarscov
usual
undetect
day
diseas
onset
present
studi
demonstr
similar
result
howev
sinc
primari
goal
studi
determin
actual
time
peak
serum
antibodi
titer
appear
collect
serum
sampl
shorter
interv
therefor
could
determin
exact
time
point
peak
serum
antibodi
titer
appear
woo
et
al
show
iggspecif
antibodi
sarscov
last
day
howev
studi
tendenc
toward
continu
drop
igg
titer
note
day
diseas
onset
rais
question
long
iggspecif
antibodi
would
actual
last
studi
demonstr
specif
igg
antibodi
persist
year
diseas
onset
addit
data
also
demonstr
drop
titer
iggspecif
antibodi
much
slower
month
diseas
onset
earlier
period
diseas
cours
think
strength
present
studi
none
enrol
patient
underli
diseas
contract
sarscov
mean
immun
respons
sarscov
infect
therefor
assum
repres
patient
normal
immun
system
addit
knowledg
studi
longest
followup
period
antibodi
respons
sarscov
write
accord
data
igm
sarscov
usual
becam
undetect
month
diseas
onset
titer
igg
becam
much
lower
initi
level
month
diseas
onset
therefor
posit
igm
result
high
titer
igg
sarscov
might
use
determin
whether
patient
recent
sarscov
infect
although
patient
receiv
steroid
one
compon
treatment
sar
still
exhibit
posit
antibodi
respons
sarscov
find
steroid
treatment
interfer
antibodi
respons
sarscov
infect
also
demonstr
one
previou
studi
previou
studi
indic
initi
crp
level
independ
factor
predict
mortal
sar
patient
peiri
et
al
propos
exacerb
clinic
condit
second
week
diseas
cours
sar
patient
correl
appear
immun
respons
assum
clinic
exacerb
might
due
uncontrol
immun
respons
howev
initi
peak
crp
level
show
signific
correl
titer
igg
present
studi
might
crp
stood
nonspecif
host
respons
thu
necessarili
correl
host
specif
immun
respons
patient
develop
respiratori
failur
sar
diseas
cours
significantli
higher
igg
titer
develop
respiratori
failur
although
number
case
respiratori
failur
present
studi
small
find
might
suggest
correl
clinic
outcom
specif
humor
immun
respons
sar
patient
limit
present
studi
first
check
neutral
antibodi
sarscov
cultur
sarscov
restrict
sake
safeti
weak
point
studi
understand
whole
humor
respons
sarscov
infect
howev
recent
studi
temperton
et
al
demonstr
neutral
antibodi
may
last
day
diseas
onset
second
use
antibodi
test
ifa
enzymelink
immunosorb
assay
determin
antibodi
respons
compar
result
determin
ifa
howev
previou
studi
demonstr
antibodi
respons
determin
ifa
enzymelink
immunosorb
assay
similar
third
sar
patient
surviv
treat
hospit
follow
year
enrol
studi
surviv
sar
patient
recov
clinic
month
agre
follow
long
time
antibodi
respons
sarscov
infect
patient
thu
might
repres
whole
spectrum
patient
especi
patient
underli
diseas
andor
impair
immun
system
summari
work
outlin
evolut
period
titer
specif
antibodi
sarscov
sar
patient
pneumonia
diseas
cours
result
show
antisarscov
igm
might
use
determin
whether
patient
recent
sarscov
infect
also
demonstr
antisarscov
igg
may
persist
year
ill
howev
still
known
long
virusspecif
serum
igg
antibodi
may
persist
infect
sarscov
